Former New York Times reporter Donald McNeil had an interesting Medium piece on how antitrust law could be impeding the development of effective treatments for COVID-19. McNeil argued that COVID-19 treatments that were developed by Pfizer and Merck, and are now in the final stages of testing, may work best when taken together. He argues More

The post In Fighting COVID-19, Intellectual Property, Not Antitrust, is the Real Problem appeared first on CounterPunch.org.

This post was originally published on CounterPunch.org.